USE OF AT LEAST ONE EFFECTOR OF GLUTATHIONE METABOLISM, TOGETHER WITH ALPHA-LIPONIC ACID FOR THE TREATMENT OF LUNG DISEASES

摘要

The invention relates to the use of at least one effector of glutathione metabolism, together alpha liponic acid, the salts and/or prodrugs thereof for simultaneous or timed cytoprotective treatment of chronically obstructive lung diseases.